i(7)(q10) by Mohamed, Anwar N
Leukaemia Section 
Short Communication 
Atlas Genet Cytogenet Oncol Haematol. 2017; 21(11) 414 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS OPEN ACCESS JOURNAL 
i(7)(q10) 
Anwar N Mohamed 
Cytogenetics laboratory, Pathology Department, Detroit Medical Center, Wayne State University 
School of Medicine, Detroit, MI USA amohamed@dmc.org 
Published in Atlas Database: January 2017 
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/i7q10ID1077.html 
Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/68999/01-2017-i7q10ID1077.pdf 
DOI: 10.4267/2042/68999
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2017 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
Abstract 
Isochromosome 7q, i(7)(q10), is a rare recurrent 
aberration found in various hematological 
neoplasms. In Mitelman's data base, i(7q) is the sixth 
most common isochromosome after i(17q), i(8q), 
i(1q), i(12p), and i(6p) in human neoplasms. The 
incidence of this abnormality, and genes involved 
are presented in this review. 
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Identity 
Isochromosome 7q consists of two identical copies 
of the long-arm (q) of chromosome 7 fused at the 
centromere but has lost the short-arm (p) 7p. The 
subsequent genetic imbalances of the karyotype with 
this abnormality results in loss of one copy of 7p and 
gain of 7q, thus neoplastic cells apparently suffer 
from an aberrant gene dosage effect (Martens, et al 
1994). 
Clinics and pathology 
Note 
Diseases Hepatosplenic T cell lymphoma (HSTL); 
Shwachman-Diamond syndrome (SDS); Acute 
lymphoblastic leukemia (ALL); Myelodysplastic 
syndrome (MDS) and Acute myeloid leukemia 
(AML) 
Disease 
Shwachman Diamond syndrome (SDS) 
Note 
Shwachman-Diamond syndrome (SDS) is an 
autosomal recessive disorder, characterized by 
exocrine pancreatic insufficiency, skeletal 
abnormalities and bone marrow dysfunction.  
The disease manifests with neutropenia, but anemia, 
thrombocytopenia, or aplastic anemia may as well 
occur. SDS patients have a high risk to develop 
myelodysplastic syndrome and/or acute myeloid 
leukemia (MDS/AML).  
The frequency of leukemia in patients with this 
syndrome is as much as 36% by age 30 years and 
increases to 71% by age 50 years.   
Around 90% of patients with clinical features of SDS 
have biallellic mutations in the SBDS gene that is 
mapped to chromosome 7q11.2 region.  
The incidence of Shwachman-Diamond syndrome 
has been estimated at one case in 77,000 population 
using comparison cystic fibrosis data. 
Cytogenetics 
SDS patients often show acquired clonal 
chromosomal abnormalities in their bone marrow 
even in the absence of accompanying hematological 
disorders.   
The most frequent is the i(7)(q10), which may 
account up to 44% of the cases with abnormal 
karyotype followed by monosomy 7 or 7q in 33% 
whereas the del(20)(q11) is found in around 16% of 
patients.  
Recent reviews of the literature data have revealed 
that SDS with the i(7q) do not develop MDS or 
transform to AML, and rarely accumulate secondary 
chromosomal changes during the course of disease. 
In addition, i(7q) has been rarely seen in SDS 
patients who developed MDS/AML. 
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Figure 1 Hyperdiploid karyotype from a child diagnosed with ALL showing i(7)(q10) i(7q), G-banding - Anwar N Mohamed; 
Insert: i(7)(q10), R- banding - Jean-Loup Huret (left), Courtesy Christiane Charrin (right). 
 
Genes 
SBDS gene may play an important role in regulating 
the Fas-mediated apoptosis pathway and may be 
responsible for the reduced cellularity in the bone 
marrow and exocrine pancreas of patients with 
Shwachman-Diamond syndrome.  Mutational 
analysis of SBDS gene revealed that SDS is caused 
by two common mutations, (c.183_184TA>CT and 
c.258+2T>C), in exon 2 of the gene. As the SBDS 
gene is located on 7q11, bone marrow cells with the 
i(7)(q10) have three copies of this gene. In all eight 
cases studied the i(7)(q10) carried two copies of the 
c.258+2T>c mutation. They suggest that, as the 
c.258+2T>C mutation still allows the production of 
some amount of normal protein, this may contribute 
to the low incidence of MDS/AML in SDS patients 
with i(7q) ( Minelli et al 2012 ). 
Prognosis 
Studies suggests that SDS with i(7q) represents a 
much less aggressive disease with low risk to 
develop MDS/AML than SDS patients with -7/7q or 
complex karyotype. This finding has impacted the 
management of children with SDS, as hematopoietic 
stem cell transplantation is no longer considered in 
patients with the i(7q) (Cunningham et al 2003). 
Disease 
Hepatosplenic T-cell lymphoma (HSTL) 
Note 
HSTL is a rare and clinically aggressive subtype of 
peripheral T-cell lymphoma, recognized as a distinct 
clinico-pathological entity in the 2008 WHO 
classification. Patients are predominantly young men 
usually present with isolated hepatosplenomegaly 
and thrombocytopenia due to malignant T-cell 
proliferation in the sinusoids of the liver, sinuses and 
red pulp of the spleen, and sinuses of the bone 
marrow (Belhadj  et al 2003) 
Pathology 
Morphology:  The cells are monotonous, medium-
sized lymphoid cells with round or slightly irregular 
nuclei, loosely condensed chromatin, and a moderate 
amount of pale cytoplasm. Mitotic activity is 
generally low. Histologic transformation to large cell 
or blastic morphology may occur with disease 
progression.  
Immunophenotype:  HSTL is derived from the 
cytotoxic memory T-cells responsible for innate 
immunity. Cells express CD2, surface CD3, and 
CD7 but CD56 expression is variable. CD4, CD5 
and CD8 are not expressed. Most cases of HSTL 
express the gamma/delta T cell receptor (TCR), but 
rare cases express the alpha/beta TCR. The cytotoxic 
granule protein TIA-1 is expressed but perforin and 
granzyme B are absent. 
Cytogenetics 
Conventional cytogenetics and fluorescence in situ 
hybridization (FISH) demonstrate that i(7q) is the 
primary chromosomal aberration in HSTL detected 
in almost all cases.  The most common 
accompanying secondary alterations are trisomy 8, 
loss of sex chromosome, deletion of 11q and gain 
extra copies of i(7q). The increase number of i(7q) is 
associated with cytological features of HSTL 
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progression (.Jonveaux P 1996; Alonsozana EL et al, 
1997). 
Genes 
The contribution of i(7q) aberration to the 
pathogenesis of HSTL has been addressed recently. 
Combined gene expression profiling and array-based 
comparative genomic hybridization (CGH) of 
several HSTL tumors recently reported by Travert et 
al showed downregulation of 7p genes, particularly 
CYCS, IKZF1, HUS1 and CBX3, and upregulation 
of 7q genes, including the putative oncogene 
PTPN12 (Travert et al 2012). Furthermore, Ferreiro 
et al studied six HSTL tumors positive for i(7q) 
including HSTL-derived cell line using high 
resolution array CGH; all exhibited a constant loss 
of 7p22.1p14.1 and gain of 7q22.11q31.1.  On the 
other hand, the RNA-sequencing did not identify any 
disease-defining mutation or gene fusion suggesting 
that chromosome 7 genomic imbalances are the 
major events in the pathogenesis of HSTL. Based on 
the integrated genomic and transcriptomic data, 
Ferreiro et al assumed that loss of 7p sequences is 
critical for the development of HSTL. This 
aberration associates with an enhanced transcription 
of CHN2 and overexpression of β2-chimerin, which 
likely affects the NFATC2 related pathway and leads 
to a proliferative response. Whereas gain of 7q 
correlates with upregulation of several genes, 
including ABCB1, RUNDC3B and PPP1R9A, 
providing growth advantage to lymphoma cells and 
contributing to their intrinsic chemo-resistance and 
aggressiveness (Finalet Ferreiro et al 2014). 
Prognosis 
HSTL is a dismal disease. Treatment with various 
induction regimens has been unsatisfactory, with 
variable response rates, high relapse rates, and a 
short median survival of 8 months. 
Disease 
Other lymphoproliferaive neoplasms 
Note 
The incidence of isochromosome 7q in other 
peripheral T-cell lymphomas has not been well 
defined. In a single study, using two color FISH 
probes, i(7q) was identified in 4 tumor specimens 
from 94 cases; two cases of extranodal NK/T-cell 
lymphoma, nasal type, and two cases of anaplastic 
lymphoma kinase-negative anaplastic large cell 
lymphoma (Feldman et al, 2008). The biologic 
significance of i(7q) in ALK- ALCL and NKTL is 
unknown. 
Disease 




In a large collaborative study of a newly diagnosed 
pediatric ALL, i(7q) was reported in  0.8% of cases. 
Although i(7q) is found as sole structural 
abnormality in few cases, usually it accompanies 
other primary chromosomal changes most frequently 
hyperdiploidy followed by t(1;19), t(9;22), and 
t(4;11) (Figure 1). The leukemic cells with i(7q) 
have had B-lineage immunophenotype and there 
were no other distinguishing clinical or laboratory 
features in this group (Pui, et al, 1992). The 





In MDS and AML, i(7q) is very rare and mostly 
occurs in the setting of complex chromosomal 
changes. I(7q) was reported in a child of a transient 
MDS associated with a clonal marrow cytogenetic 
abnormality of isochromosome 7q. Without 
intervention, the bone marrow cytogenetics reverted 
to normal and there was complete hematologic 
recovery (Leung  et al, 2003). Additionally, i(7q) has 
been reported as a sole acquired abnormality in three 
sporadic cases of Down syndrome with AML (Wong 
et al 2006). 
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